Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study

CONCLUSION: In our retrospective study, the effectiveness and toxicity of ICI therapy were similar to those determined in clinical trials. Our findings suggest that ICIs could be effective and well tolerated by people with advanced CSCC who are ineligible for clinical trials.PMID:38212673 | DOI:10.5694/mja2.52199

Source: Med J Aust - January 11, 2024 Category: General Medicine Authors: Luke S McLean Annette M Lim Mathias Bressel Jenny Lee Rahul Ladwa Alexander D Guminski Brett Hughes Samantha Bowyer Karen Briscoe Samuel Harris Craig Kukard Rob Zielinski Muhammad Alamgeer Matteo Carlino Jeremy Mo John J Park Muhammad A Khattak Fiona Day Source Type: research